Characterization of a drug resistant MCF-7 breast cancer cell line developed by repeated cycles of 5-Fluorouracil (5-FU) therapy
Crossref DOI link: https://doi.org/10.30574/ijsra.2024.13.2.2166
Published Online: 2024-11-30
Update policy: https://doi.org/10.30574/ijsra.ourcrossmarkpolicy
Erebi Patricia Tawari,
Melvin Peremobowei Ere,